Rexahn management update

Rexahn Pharmaceuticals Inc. (NYSE-M:RNN), Rockville, Md. Business: Cancer, Neurology, Genitourinary Hired: Peter Suzdak as CEO, formerly CSO of Corridor Pharmaceuticals Inc.; he succeeds Chang Ahn, w...